Montelukast Prescribing at THE RED HOUSE SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
990
Total Quantity
49.0K
NHS Cost
£2.7K
vs National Avg
+44.6%
THE RED HOUSE SURGERY prescribed 990 items of Montelukast over the last 12 months at a cost of £2,716 to the NHS. This is 44.6% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
83
Jul 2026
82
Jul 2026
89
Jul 2026
78
Jul 2026
83
Jul 2026
78
Jul 2026
74
Jul 2026
85
Jul 2026
90
Jul 2026
69
Jul 2026
91
Jul 2026
88
Prescribing Details
| Total Items | 990 |
|---|---|
| Total Quantity | 49,017 |
| Total NHS Cost | £2,716 |
| Presentations | 5 different forms |
| vs National Average | +44.6% |
Montelukast Prescribing Comparison
| This practice | 990 items |
|---|---|
| National average per practice | 685 items |
| Difference | +44.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.